David J. Blackbourn
David John Blackbourn PhD FRSB is currently Professor of Virology and Director of the Institute of Medical Sciences at the University of Aberdeen. His research interests emphasise virus understanding how viruses have evolved to manipulate immune responses. Having previously been Head of the School of Biosciences and Medicine for 8 years. He is also a co-founder of Ducentis BioTherapeutics to produce a novel anti-inflammatory therapeutic drug and until September 2022, was non-executive board member. Blackbourn is an Editor-in-Chief of ''FEMS Microbiology Reviews''. Provided by Wikipedia-
1by Rachel Wheat, Claudia Roberts, Tim Waterboer, Jane Steele, Jerry Marsden, Neil M. Steven, David J. BlackbournGet full text
Published 2014-05-01
Article -
2
-
3by Brian R Jackson, James R Boyne, Marko Noerenberg, Adam Taylor, Guillaume M Hautbergue, Matthew J Walsh, Rachel Wheat, David J Blackbourn, Stuart A Wilson, Adrian WhitehouseGet full text
Published 2011-07-01
Article -
4by Nicole Caduff, Donal McHugh, Lisa Rieble, Catherine S. Forconi, John M. Ong’echa, Peter O. Oluoch, Ana Raykova, Anita Murer, Michelle Böni, Lara Zuppiger, Thomas F. Schulz, David J. Blackbourn, Obinna Chijioke, Ann M. Moormann, Christian MünzGet full text
Published 2021-05-01
Article